Holen Sie sich die Stockscreener-App
13.62
7.47%
-1.10
Finanzdaten der Iovance Biotherapeutics Inc-Aktie (IOVA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
39.04%
99.31
|
71.43 | 86.77 | 67.45 | 59.95 |
| Cost Of Revenue |
2.58%
43.59
|
42.50 | 43.11 | 38.48 | 56.66 |
| Research and Development |
5.82%
58.85
|
62.49 | 71.20 | - | - |
| Costs And Expenses |
0.82%
151.22
|
152.47 | 160.23 | 162.36 | 173.73 |
| Depreciation and Amortization |
11.25%
9.50
|
8.539 | 9.517 | 9.007 | - |
| Operating Income/Loss |
35.95%
-51.91
|
-81.04 | -73.46 | -94.90 | -113.77 |
| Income/Loss From Continuing Operations Before Tax |
38.92%
-48.69
|
-79.71 | -71.72 | -93.66 | -109.67 |
| Income Tax Expense/Benefit, Deferred |
106.47%
-1.373
|
-0.665 | 0.184 | -2.405 | 1.988 |
| Income Tax Expense/Benefit |
106.47%
-1.373
|
-0.665 | 0.184 | -2.405 | 1.988 |
| Net Income/Loss |
40.14%
-47.31
|
-79.05 | -71.90 | -91.25 | -111.66 |
| Basic Average Shares |
7.57%
0.4502
|
0.4185 | - | 0.364 | 0.3345 |
| Diluted Average Shares |
7.57%
0.4502
|
0.4185 | - | - | 0.3345 |
| Basic Earnings Per Share |
42.11%
-0.11
|
-0.19 | - | -0.25 | -0.33 |
| Diluted Earnings Per Share |
42.11%
-0.11
|
-0.19 | - | - | -0.33 |
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):